Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)
26.38
-0.12 (-0.45%)
Nov 20, 2026, 3:00 PM CST
SHA:603882 Market Cap
SHA:603882 has a market cap or net worth of 12.05 billion as of November 20, 2026. It is the 6,635th most valuable company in the world and the 1,159th biggest in China. Its market cap has decreased by 13.15% in one year.
Market Cap
12.05B
Enterprise Value
10.65B
Revenue
5.89B
Global Rank
Country Rank
#1,159 China
PE Ratio
43.62
ChartMarket Cap Chart
Since September 8, 2017, SHA:603882's market cap has increased from 4.57B to 12.05B, an increase of 163.61%. That is a compound annual growth rate of 11.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 12.05B | -8.31% |
| Dec 31, 2025 | 13.14B | 3.91% |
| Dec 31, 2024 | 12.64B | -56.89% |
| Dec 29, 2023 | 29.33B | -19.71% |
| Dec 30, 2022 | 36.53B | -29.55% |
| Dec 31, 2021 | 51.85B | -11.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hangzhou Tigermed Consulting | 34.89B |
| Joinn Laboratories(China)Co.,Ltd. | 21.80B |
| BGI Genomics | 12.58B |
| Dian Diagnostics Group | 10.60B |
| Beijing Strong Biotechnologies,Inc. | 7.00B |
| Amoy Diagnostics | 6.29B |
| Shanghai Runda Medical Technology | 4.42B |
| Cowealth Medical China | 3.41B |